<section><div class="Schedule"><header><h2 class="scheduleLabel" id="h-3.141516"><span class="scheduleLabel">SCHEDULE III</span><span class="OriginatingRef">(Sections 2 to 7, 29, 55 and 60)</span></h2></header><figure><ul class="noBullet"><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">1</span> </div><div class="listItemText3-5"><span class="Repealed">[Repealed, 2012, c. 1, s. 45]</span></div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">2</span> </div><div class="listItemText3-5">Methylphenidate (α–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">3</span> </div><div class="listItemText3-5">Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">4</span> </div><div class="listItemText3-5">Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">5</span> </div><div class="listItemText3-5">Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">6</span> </div><div class="listItemText3-5">N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">7</span> </div><div class="listItemText3-5">N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">8</span> </div><div class="listItemText3-5">N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">9</span> </div><div class="listItemText3-5">Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">10</span> </div><div class="listItemText3-5">Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">11</span> </div><div class="listItemText3-5">Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">12</span> </div><div class="listItemText3-5">Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">13</span> </div><div class="listItemText3-5">N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">14</span> </div><div class="listItemText3-5">1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">15</span> </div><div class="listItemText3-5">1–Phenyl–N–propylcyclohexanamine and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">16</span> </div><div class="listItemText3-5">Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">17</span> </div><div class="listItemText3-5">Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">18</span> </div><div class="listItemText3-5">4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">19</span> </div><div class="listItemText3-5">Cathinone ((–)–α–aminopropiophenone) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">20</span> </div><div class="listItemText3-5">Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">21</span> </div><div class="listItemText3-5">2–Methylamino–1–phenyl–1–propanone and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">22</span> </div><div class="listItemText3-5">1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">23</span> </div><div class="listItemText3-5">1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">24</span> </div><div class="listItemText3-5"><span class="Repealed">[Repealed, SOR/2016-73, s. 1]</span></div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">25 and 26</span> </div><div class="listItemText3-5"><span class="Repealed">[Repealed, 2012, c. 1, s. 46]</span></div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">27</span> </div><div class="listItemText3-5">Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">28</span> </div><div class="listItemText3-5">Etryptamine (3-(2-aminobutyl)indole) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">29</span> </div><div class="listItemText3-5">Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">30</span> </div><div class="listItemText3-5">Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">31</span> </div><div class="listItemText3-5">Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">32</span> </div><div class="listItemText3-5">Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">33</span> </div><div class="listItemText3-5">Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">34</span> </div><div class="listItemText3-5">Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">35</span> </div><div class="listItemText3-5">2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description :</div></div><figure><ul class="noBullet"><li><div class="listItemBlock0"><div class="listItemLabel"></div><div class="listItemText3-5">any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including</div></div><figure><ul class="noBullet"><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">(1)</span> </div><div class="listItemText3-5">4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe)</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">(2)</span> </div><div class="listItemText3-5">4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe)</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">(3)</span> </div><div class="listItemText3-5">4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe)</div></div></li><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">(4)</span> </div><div class="listItemText3-5">4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)</div></div></li></ul></figure></li></ul></figure></li></ul></figure><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">1996, c. 19, Sch. III</li><li class="HistoricalNoteSubItem"> SOR/97-230, ss. 7 to 10</li><li class="HistoricalNoteSubItem"> SOR/98-173, s. 1</li><li class="HistoricalNoteSubItem"> SOR/2000-220, s. 1</li><li class="HistoricalNoteSubItem"> SOR/2003-32, ss. 2, 3, 4(F), 5</li><li class="HistoricalNoteSubItem"> SOR/2003-412</li><li class="HistoricalNoteSubItem"> SOR/2005-235, s. 2</li><li class="HistoricalNoteSubItem"> 2012, c. 1, ss. 45, 46</li><li class="HistoricalNoteSubItem"> SOR/2012-66</li><li class="HistoricalNoteSubItem"> SOR/2016-73</li><li class="HistoricalNoteSubItem"> SOR/2016-107, s. 2</li></ul></div></div></section>